← Open Payments lookup

JILL HUDE: Open Payments

NPI 1568419489 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$848 in 40 payments from 13 companies in 2025. Trend: 2023 $303 · 2024 $736 · 2025 $848

Food & beverage: $848
CompanyPaymentsAmount
Janssen Biotech, Inc.8$150
UCB, Inc.4$107
Novartis Pharmaceuticals Corporation4$84
Botanix SB Inc3$72
ABBVIE INC.3$70
Regeneron Healthcare Solutions, Inc.3$68
LEO Pharma Inc.3$61
Galderma Laboratories, L.P.3$54
Incyte Corporation2$52
Amgen Inc.3$52

Products named: TREMFYA, Bimzelx, SOFDRA, DUPIXENT, COSENTYX, ADBRY, NEMLUVIO, OPZELURA.

Industry payments across TX — which companies pay providers there.